Effects of flavonoid-containing beverages and egcg on endothelial function

Journal of the American College of Nutrition

Volumn 26, Issue 4, 2007, Pages 366S-372S

  Shenouda, Sherene M ^a   Vita, Joseph A ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

EGCG; Endothelial function; Epigallocatechin gallate; Flavonoids

Indexed keywords

FLAVONOID;

ATHEROGENESIS; ATHEROSCLEROSIS; BEVERAGE; CACAO; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CONFERENCE PAPER; DIET SUPPLEMENTATION; DYSLIPIDEMIA; FOOD COMPOSITION; GRAPE JUICE; HOMEOSTASIS; HUMAN; LIFESTYLE; RED WINE; RISK FACTOR; RISK REDUCTION; TEA; VASCULAR ENDOTHELIUM;

ANTIOXIDANTS; ATHEROSCLEROSIS; BEVERAGES; CARDIOVASCULAR DISEASES; CATECHIN; ENDOTHELIUM, VASCULAR; FLAVONOIDS; HUMANS; RISK FACTORS;

EID: 35348815562     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.2007.10719625     Document Type: Article

References (75)

1. Widlansky ME, Gokce N, Keaney JF, Jr., Vita JA: The clinical implications of endothelial dysfunction. J Am Coll Cardiol 42: 1149–1160, 2003.
2. Huang AL, Vita JA: Effects of systemic inflammation on endothelium-dependent vasodilation. Trends Cardiovasc Med 16:15–20, 2006.
3. Deanfield JE, Halcox JP, Rabelink TJ: Endothelial function and dysfunction: testing and clinical relevance. Circulation 115:1285–1295, 2007.
4. Lerman A, Zeiher AM: Endothelial function: cardiac events. Circulation 111:363–368, 2005.
5. Vita JA, Keaney JF, Jr.: Endothelial function: A barometer for cardiovascular risk? Circulation 106:640–642, 2002.
6. Hamburg NM, Vita JA. Endothelial dysfunction in atherosclerosis: Mechanisms of impaired nitric oxide bioactivity. In: Molecular mechanisms of atherosclerosis. Loscalzo J, ed. 2006. Taylor & Francis, London.
7. Malek AM, Alper SL, Izumo S: Hemodynamic shear stress and its role in atherosclerosis. JAMA 282:2035–2042, 1999.
8. Sherman DL, Keaney JF, Jr., Biegelsen ES, Duffy SJ, Coffman JD, Vita JA: Pharmacological concentrations of ascorbic acid are required for the beneficial effects on endothelial vasomotor function in hypertension. Hypertension 35:936–941, 2000.
9. Jackson TS, Xu A, Vita JA, Keaney JF, Jr.: Ascorbate prevents the interaction of superoxide and nitric oxide only at very high physiological concentrations. Circ Res 83:916–922, 1998.
10. Münzel T, Keaney JF, Jr.: Are ACE-inhibitors a “magic bullet” against oxidative stress? Circulation 104:1571–1574, 2001.
11. Vita JA: Nitric oxide-dependent vasodilation in human subjects. Methods Enzymol 359:186–200, 2002.
12. McMackin CJ, Vita JA: Update on nitric oxide-dependent vasodilation in human subjects. Methods Enzymol 396:541–553, 2005.
13. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, Deanfield J, Drexler H, Gerhard-Herman M, Herrington D, Vallance P, Vita J, Vogel R: Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery. A report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 39:257–265, 2002.
14. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, Finkel T: Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348:593–600, 2003.
15. Ludmer PL, Selwyn AP, Shook TL, Wayne RR, Mudge GH, Alexander RW, Ganz P: Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 315:1046–1051, 1986.
16. Vita JA, Treasure CB, Nabel EG, McLenachan JM, Fish RD, Yeung AC, Vekshtein VI, Selwyn AP, Ganz P: Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation 81:491–497, 1990.
17. Benjamin EJ, Larson MG, Kupka MJ, Mitchell GF, Keaney JF, Jr., Vasan RS, Lehman B, Fananapazir L, Osypiuk E, Vita JA: Crosssectional correlates of brachial artery endothelial function in the community: The NHLBI’s Framingham Heart Study. Circulation 104:111-152, 2002.
18. Nishimura RA, Lerman A, Chesebro JH, Ilstrup DM, Hodge DO, Higano ST, Holmes DR, Tajik J: Epicardial vasomotor responses to acetylcholine are not predicted by coronary atherosclerosis as assessed by intracoronary ultrasound. J Am Coll Cardiol 26:41–49, 1995.
19. Levine GN, Keaney JF, Jr., Vita JA: Cholesterol reduction in cardiovascular disease: Clinical benefits and possible mechanisms. N Engl J Med 332:512–521, 1995.
20. Suwaidi JA, Hamasaki S, Higano ST, Nishimura RA, Holmes DR, Lerman A: Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 101:948–954, 2000.
21. Schachinger V, Britten MB, Zeiher AM: Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 101:1899–1906, 2000.
22. Halcox JPJ, Schenke WH, Zalos G, Mincemoyer R, Prasad A, Waclawiw MA, Nour KRA, Quyyumi AA: Prognostic value of coronary vascular endothelial function. Circulation 106:653–658, 2002.
23. Heitzer T, Schlinzig T, Krohn K, Meinertz T, Munzel T: Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 104: 2673–2678, 2001.
24. Perticone F, Ceravolo R, Pujia A, Ventura G, Iacopino S, Scozzafava A, Ferraro A, Chello M, Mastroroberto P, Verdecchia P, Schillaci G: Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation 104:191–196, 2001.
25. Gokce N, Keaney JF, Jr., Menzoian JO, Watkins M, Hunter L, Duffy SJ, Vita JA: Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function. Circulation 105:1567–1572, 2002.
26. Yeboah J, Crouse JR, Hsu FC, Burke GL, Herrington DM: Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: the Cardiovascular Health Study. Circulation 115:2390–2397, 2007.
27. Anderson TJ: Prognostic significance of brachial flow-mediated vasodilation. Circulation 115:2373–2375, 2007.
28. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, Bohm M, Nickenig G: Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 353:999–1007, 2005.
29. Stensvold I, Tverdal A, Solvoll K, Foss OP: Tea consumption, relationship to cholesterol, blood pressure, and coronary and total mortality. Prev Med 21:546–553, 1992.
30. Hertog MGL, Feskens EJM, Hollman PCH, Martijn B, Kromhout D: Dietary antioxidant flavonoids and risk of coronary heart disease: The Zutphen Elderly Study. Lancet 342:1007–1011, 1993.
31. Keli SO, Hertog MGL, Feskens EJM, Kromhout D: Dietary flavanoids, antioxidant vitamins, and incidence of stroke: the Zutphen study. Arch Intern Med 156:637–642, 1996.
32. Knekt P, Jarvinen R, Reunanen A, Maatela J: Flavonoid intake and coronary mortality in Finland: a cohort study. Br Med J 312:478–481, 1996.
33. Hertog MG, Sweetnam PM, Fehily AM, Elwood PC, Kromhout D: Antioxidant flavonols and ischemic heart disease in a Welsh population of men: The Caerphilly Study. Am J Clin Nutr 65:1489–1494, 1997.
34. Sesso HD, Gaziano JM, Buring JE, Hennekens CH: Coffee and tea intake and the risk of myocardial infarction. Am J Epidemiol 149:162–167, 1999.
35. Yochum L, Kushi LH, Meyer K, Folsom AR: Dietary flavonoid intake and risk of cardiovascular disease in postmenopausal women. Am J Epidemiol 149:943–949, 1999.
36. Geleijnse JM, Launer LJ, Van der Kuip DA, Hofman A, Witteman JC: Inverse association of tea and flavonoid intakes with incident myocardial infarction: the Rotterdam Study. Am J Clin Nutr 75: 880–886, 2002.
37. Mukamal KJ, Maclure M, Muller JE, Sherwood JB, Mittleman MA: Tea consumption and mortality after acute myocardial infarction. Circulation 105:2476–2481, 2002.
38. Mink PJ, Scrafford CG, Barraj LM, Harnack L, Hong CP, Nettleton JA, Jacobs DR, Jr.: Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women. Am J Clin Nutr 85:895–909, 2007.
39. Brown CA, Bolton-Smith C, Woodward M, Tunstall-Pedoe H: Coffee and tea consumption and the prevalence of coronary heart disease in men and women: Results from the Scottish Health Study. J Epidemiol Community Health 47:171–175, 1993.
40. Rimm EB, Katan MB, Ascherio A, Stampfer MJ, Willett WC: Relation between intake of flavonoids and risk for coronary heart disease in male health professionals. Ann Intern Med 125:384–389, 1996.
41. Sesso HD, Paffenbarger RS, Jr., Oguma Y, Lee IM: Lack of association between tea and cardiovascular disease in college alumni. Int J Epidemiol 32:527–533, 2003.
42. Vita JA: Polyphenols and cardiovascular disease: effects on endothelial and platelet function. Am J Clin Nutr 81:292S–297S, 2005.
43. Peters U, Poole C, Arab L: Does tea affect cardiovascular disease? a meta-analysis. Am J Epidemiol 154:495–503, 2001.
44. Klatsky AL, Friedman GD, Armstrong MA, Kipp H: Wine, liquor, beer, and mortality. Am J Epidemiol 158:585–595, 2003.
45. Di Castelnuovo A, Rotondo S, Iacoviello L, Donati MB, de Gaetano G: Meta-analysis of wine and beer consumption in relation to vascular risk. Circulation 105:2836–2844, 2002.
46. Lichtenstein AH, Appel LJ, Brands M, Carnethon M, Daniels S, Franch HA, Franklin B, Kris-Etherton P, Harris WS, Howard B, Karanja N, Lefevre M, Rudel L, Sacks F, Van Horn L, Winston M, Wylie-Rosett J: Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation 114:82–96, 2006.
47. Popkin BM, Armstrong LE, Bray GM, Caballero B, Frei B, Willett WC: A new proposed guidance system for beverage consumption in the United States. Am J Clin Nutr 83:529–542, 2006.
48. Diaz MN, Frei B, Vita JA, Keaney JF, Jr.: Antioxidants and atherosclerotic heart disease. N Engl J Med 337:408–417, 1997.
49. Stein JH, Keevil JG, Wiebe DA, Aeschlimann S, Folts JD: Purple grape juice improves endothelial function and reduces the susceptibility of LDL cholesterol to oxidation in patients with coronary artery disease. Circulation 100:1050–1055, 1999.
50. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebocontrolled trial. Lancet 360:23–33, 2002.
51. Yusuf S, Dagenais G, Pogue J, Bosch J, Sleight P: Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 342:154–160, 2000.
52. O’Reilly JD, Mallet AI, McAnlis GT, Young IS, Halliwell B, Sanders TA, Wiseman H: Consumption of flavonoids in onions and black tea: lack of effect on F(2)-isoprostanes and autoantibodies to oxidized LDL in healthy humans. Am J Clin Nutr 73:1040–1044, 2001.
53. Lotito SB, Frei. B.: Consumption of flavonoid-rich foods and increased plasma antioxidant capacity in humans: Cause, consequence, or epiphenomenon? Free Rad Biol Med 41:1727–1746, 2006.
54. Duffy SJ, Keaney JF, Jr., Holbrook M, Gokce N, Swerdloff PL, Frei B, Vita JA: Short-and long-term black tea consumption reverses endothelial dysfunction in patients with coronary artery disease. Circulation 104:151–156, 2001.
55. Widlansky ME, Duffy SJ, Hamburg NM, Gokce N, Warden BA, Wiseman S, Keaney JF, Jr., Frei B, Vita JA: Effects of black tea consumption on plasma catechins, markers of oxidative stress and inflammation in patients with coronary artery disease. Free Radic Biol Med 38:499–506, 2004.
56. Hodgson JM, Puddey IB, Burke V, Watts GF, Beilin LJ: Regular ingestion of black tea improves brachial artery vasodilator function. Clin Sci (Lond) 102:195–201, 2002.
57. Hodgson JM, Croft KD, Mori TA, Burke V, Beilin LJ, Puddey IB: Regular ingestion of tea does not inhibit in vivo lipid peroxidation in humans. J Nutr 132:55–58, 2002.
58. Hirata K, Shimada K, Watanabe H, Otsuka R, Tokai K, Yoshiyama M, Homma S, Yoshikawa J: Black tea increases coronary flow velocity reserve in healthy male subjects. Am J Cardiol 93:1384–1388, A6, 2004.
59. Nagaya N, Yamamoto H, Uematsu M, Itoh T, Nakagawa K, Miyazawa T, Kangawa K, Miyatake K: Green tea reverses endothelial dysfunction in healthy smokers. Heart 90:1485–1486, 2004.
60. Chou EJ, Keevil JG, Aeschlimann S, Wiebe DA, Folts JD, Stein JH: Effect of ingestion of purple grape juice on endothelial function in patients with coronary heart disease. Am J Cardiol 88:553–555, 2001.
61. Hashimoto M, Kim S, Eto M, Iijima K, Ako J, Yoshizumi M, Akishita M, Kondo K, Itakura H, Hosoda K, Toba K, Ouchi Y: Effect of acute intake of red wine on flow-mediated vasodilatation of the brachial artery. Am J Cardiol 88:1457–1460, A9, 2001.
62. Agewall S, Wright S, Doughty RN, Whalley GA, Duxbury M, Sharpe N: Does a glass of red wine improve endothelial function? Eur Heart J 21:74–78, 2000.
63. Heiss C, Dejam A, Kleinbongard P, Schewe T, Sies H, Kelm M: Vascular effects of cocoa rich in flavan-3-ols. JAMA 290:1030–1031, 2003.
64. Heiss C, Kleinbongard P, Dejam A, Perre S, Schroeter H, Sies H, Kelm M: Acute consumption of flavanol-rich cocoa and the reversal of endothelial dysfunction in smokers. J Am Coll Cardiol 46:1276–1283, 2005.
65. Schroeter H, Heiss C, Balzer J, Kleinbongard P, Keen CL, Hollenberg NK, Sies H, Kwik-Uribe C, Schmitz HH, Kelm M: (–)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. Proc Natl Acad Sci U S A 103:1024–1029, 2006.
66. Engler MB, Engler MM, Chen CY, Malloy MJ, Browne A, Chiu EY, Kwak HK, Milbury P, Paul SM, Blumberg J, Mietus-Snyder ML: Flavonoid-rich dark chocolate improves endothelial function and increases plasma epicatechin concentrations in healthy adults. J Am Coll Nutr 23:197–204, 2004.
67. Erdman JW, Jr., Balentine D, Arab L, Beecher G, Dwyer JT, Folts J, Harnly J, Hollman P, Keen CL, Mazza G, Messina M, Scalbert A, Vita J, Williamson G, Burrowes J: Flavonoids and Heart Health: Proceedings of the ILSI North America Flavonoids Workshop, May 31–June 1, 2005, Washington, DC. J Nutr 137:718S–737S, 2007.
68. Widlansky ME, Hamburg NM, Anter E, Holbrook M, Kahn DF, Elliott JG, Keaney JF, Jr., Vita JA: Acute EGCG supplementation reverses endothelial dysfunction in patients with coronary artery disease. J Am Coll Nutr 2007;26:95–101.
69. Lorenz M, Wessler S, Follmann E, Michaelis W, Dusterhoft T, Baumann G, Stangl K, Stangl V: A constituent of green tea, epigallocatechin-3-gallate, activates endothelial nitric oxide synthase by a phosphatidylinositol-3-OH-kinase-, cAMP-dependent protein kinase-, and Akt-dependent pathway and leads to endothelial-dependent vasorelaxation. J Biol Chem 279:6190–6195, 2004.
70. Anter E, Thomas SR, Schulz E, Shapira OM, Vita JA, Keaney JF, Jr.: Activation of eNOS by the p38 MAP kinase in response to black tea polyphenols. J Biol Chem 45:46637–46643, 2004.
71. Anter E, Chen K, Shapira OM, Karas RH, Keaney JF, Jr.: p38 mitogen-activated protein kinase activates eNOS in endothelial cells by an estrogen receptor alpha-dependent pathway in response to black tea polyphenols. Circ Res 96:1072–1078, 2005.
72. Matsuo S, Nakamura Y, Takahashi M, Ouchi Y, Hosoda K, Nozawa M, Kinoshita M: Effect of red wine and ethanol on production of nitric oxide in healthy subjects. Am J Cardiol 87: 1029–1031, 2001.
73. Lekakis J, Rallidis LS, Andreadou I, Vamvakou G, Kazantzoglou G, Magiatis P, Skaltsounis AL, Kremastinos DT: Polyphenolic compounds from red grapes acutely improve endothelial function in patients with coronary heart disease. Eur J Cardiovasc Prev Rehabil 12:596–600, 2005.
74. Wang-Polagruto JF, Villablanca AC, Polagruto JA, Lee L, Holt RR, Schrader HR, Ensunsa JL, Steinberg FM, Schmitz HH, Keen CL: Chronic consumption of flavanol-rich cocoa improves endothelial function and decreases vascular cell adhesion molecule in hypercholesterolemic postmenopausal women. J Cardiovasc Pharmacol 47 Suppl 2:S177–86; discussion S206-9.:S177–S186, 2006.
75. Vlachopoulos C, Aznaouridis K, Alexopoulos N, Economou E, Andreadou I, Stefanadis C: Effect of dark chocolate on arterial function in healthy individuals. Am J Hypertens 18:785–791, 2005.